Stay informed with the latest updates for the inheritable blood disorders community.

Industry
First Hemophilia B Patient Dosed with Gene Therapy Product
NBDF & Community
Shaping the Future: Search Begins for New NHF CEO
Shaping the Future: Search Begins for New NHF CEO
Peer-Reviewed Journal Summaries
Biomarin Provides Hemophilia A Clinical Development Program Updates
Inequities in Thrombosis and Hemostasis Lab Testing the Focus of…
Peer-Reviewed Journal Summaries
FDA Places Clinical Hold on Sigilon’s Investigational Hemophilia Therapy
Gene Therapy as a Novel Approach to Achieving ITI in FVIII Inhibitors…
NBDF & Community
The King Years: A Legacy Continues
Advocacy & Legislative
Government Relations Update
Government Relations Update - May 2023
Industry
Research Blood Disorder Vial
Pfizer Highlights Phase 3 Trial Results of Marstacimab
NBDF & Community
Dr. Valentino Becomes CEO
Announcement from NHF CEO and President
NBDF & Community
It is Family: A Conversation with Saylor Behrens
NBDF & Community
Get to Know the Nevada Chapter with Jacob Murdock
Medical
DEI - Artwork of Diverse Group of People Men Women
Rare Disease Fellowship Program Now Accepting Applications!
Medical
MASAC Prophylaxis Recommendations
New MASAC Documents Approved on Physical…
Medical
Nasal Spray
Updates on Generic Desmopressin Product
Peer-Reviewed Journal Summaries
Gene Therapy Helix
MLOF Genotyping Project Informed Inhibitor Risk
Industry
Research Blood Disorder Vial
FDA Requests Additional Information on Concizumab from Novo Nordisk